BackBioNeutra Global Overview

BioNeutra Global Total Current Liabilities

Track BioNeutra Global's total current liabilities ($15M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$15.20M
↓ 8.76% YoYΔ $-1.46M vs prior year quarter

Peer trimmed avg / median

Loading

BioNeutra Global Total Current Liabilities History

Loading

BioNeutra Global vs. peers: Total Current Liabilities Comparison

Loading

BioNeutra Global Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

BioNeutra Global (BGACF) FAQ

As of the most recent data (September 2024), BGACF shows a total current liabilities of $15M. That compares with $17M in the prior-year period — down 8.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BGACF's total current liabilities is now $15M (was $17M) — a 8.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether BioNeutra Global is outperforming or lagging.

Tracking BGACF's total current liabilities over time shows whether BioNeutra Global is scaling, shrinking, or reshaping that part of the business. The current reading is $15M That compares with $17M in the prior-year period — down 8.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has BioNeutra Global's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $15M) with ownership activity and broader fundamentals.

Questions & Answers